Kevin P. Starr

Biography

 Mr. Kevin P. Starr co-founded Third Rock Ventures, LLC in 2007 and is its Partner. He focuses on the formation, development and business strategy of Therapeutics’ portfolio companies as well as actively identifying and evaluating new investments. He assumes active leadership roles in the portfolio companies, functioning as the Chief Executive Officer through the first 12 to 18 months post launch. He is Co-Founder and Partner of Third Rock Ventures II, L.P. and Third Rock Ventures, LLC. Mr. Starr is a founding investor in Prospect Pictures. He is a proven operational leader with over 25 years of experience in building, operating and management of finance, technology and operations in biotechnology companies. He is the Founder of Decibel Therapeutics, Inc. and served as its Interim Chief Executive Officer until July 13, 2016. He has been instrumental in launching and building a number of portfolio companies. He served as the Interim Chief Executive Officer of Sage Therapeutics, Inc. from October 2011 and August 14, 2013. He served as the Chief Financial Officer of Cytomed, Inc. Mr. Starr was the Chief Operating Officer from December 2001 to December 2002 and Chief Financial Officer from December 1998 to December 2002 at Millennium Pharmaceuticals, Inc. At Millennium Pharmaceuticals, he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Mr. Starr served as an Interim Chief Executive Officer of Agios Pharmaceuticals, Inc. until August 2009 and ZafGen Pharmaceuticals. He served as Vice President of Finance at Millennium BioTherapeutics from March 1998 to December 1998. Mr. Starr was a Corporate Controller and Head of Finance at Biogen Idec Ma Inc. from 1991 to February 1998. Mr. Starr was employed at Biogen MA Inc. He was the Chief Financial Officer at ChemGenics Pharmaceuticals, Inc. He served in various executive roles at Digital Equipment Corporation. Mr. Starr serves as the Chairman of Decibel Therapeutics, Inc. He serves as the Chairman at Sage Therapeutics, Inc. He served as the Chairman of Agios Pharmaceuticals, Inc. until June 23, 2015. He has been a Director of Alnylam Pharmaceuticals,

Research Interest

 Information, development and business strategy